Navigation Links
Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
Date:6/8/2009

as an (asymptomatic) adverse event, the gastrointestinal adverse event profile was similar in incidence to that reported for other currently marketed phosphate binders. There was no increase in serum calcium noted in the study.

Dr. Julia Lewis, Professor of Medicine at Vanderbilt University, the Principal Investigator in the study, commented, "This study, as well as earlier studies, suggest that Zerenex is an effective, tolerated phosphate binder that will potentially make a significant clinical addition to treating the important universally present problem of hyperphosphatemia in patients with end-stage renal disease."

Ron Bentsur, Chief Executive Officer of Keryx, stated, "The promising safety and efficacy profile of Zerenex indicates that there is significant market potential for the drug in the phosphate binder space." Mr. Bentsur continued, "We're excited to have two late stage clinical drug candidates, Zerenex and KRX-0401 (perifosine), both with compelling Phase 2 data."

About Hyperphosphatemia

In the United States, according to data from the U.S. Renal Data System, there are approximately 485,000 patients with end-stage renal disease, or ESRD, and the number of ESRD patients is projected to rise 60% to approximately 785,000 by 2020. The majority of ESRD patients, over 350,000, require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization. ESRD patients usually require treatment with phosphate-binding agents to lower and maintain serum phosphorus at acceptable levels. The need for alternative phosphate-binding agents has long been recognized, especially given the increasing prevalence of ESRD as well as shortcomings with current therapies. Zerenex has the potential to be an ef
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014) The yield so far is small, ... a low-energy, solution-based mineral substitution process to make a ... in electronics and alternative energy devices. , A paper ... the July 21 issue of the journal Inorganic ... in the inorganic and nuclear chemistry fields. The paper ...
(Date:7/20/2014)... July 20, 2014 NSG Precision ... glass optics, and spectrophotometer calibration standards ... NSG has released many products that have transformed ... has been their solid-state calibration standards. , NSG’s ... since their release in 2008. NSG started ...
(Date:7/18/2014)... mostly neutral. That is, most of the atoms ... of electrons in the outer parts of atoms equals ... As one or more electrons are plucked away ... stronger positive pull from the nucleus. This enhanced ... that those electrons are less vulnerable to the distractions ...
(Date:7/18/2014)... CHICAGO, Ill. , July 18, 2014 ... an infographic highlighting AbbVie and Shire,s complementary ... combination. A copy of the ... website at:  http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents ... Takeover Code, a copy of this announcement ...
Breaking Biology Technology:Oregon chemists eye improved thin films with metal substitution 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3Highly charged ions 2Highly charged ions 3Highly charged ions 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7
... Sciences,Corporation (NYSE: CSC ) today announced that ... president of its North American Public Sector,business unit, ... and Modern,Healthcare magazines, annual ranking of the 50 ... both magazines nominated 7,300,physician executives for the fourth ...
... SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, ... and NovaSecta in,their CRO Service Alliance CROSA ... companies. Tigermed,s expertise in clinical,development complements the ... the alliance., Sundia Meditech, United PharmaTech, ...
... SEATTLE, April 30 Dendreon Corporation,(Nasdaq: DNDN ) today ... May., Deutsche Bank 33rd Annual Health Care Conference ... a.m. ET, Bank of America Health Care Conference ... 11:00 a.m. ET, Rodman & Renshaw 5th Annual ...
Cached Biology Technology:CSC's Dr. Robert M. Wah Makes Top 10 in 50 Most Powerful Physician Executives List 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3
(Date:7/21/2014)... How many times do we see an innovation and ... Our minds start turning towards thoughts of our own ... inspiration is the concept behind the International Space Station ... scientists see what their colleagues have going on in ... , "Our goal is to encourage investigators to propose ...
(Date:7/21/2014)... "dog" have meaning? If you say "dog" to a ... State University philosopher Elliott Wagner aims to address these ... on long-standing philosophical questions about semantic meaning. Wagner, assistant ... mathematician are collaborating to use game theory to analyze ... order a cappuccino at a coffee shop, I usually ...
(Date:7/21/2014)... disease often results from the strength of immune response, ... response, rather than attacking the virus, might be a ... of the University of Washington, Seattle. She and her ... just that for the H7N9 influenza, and their work ... for this highly virulent strain. The research is published ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2Potential new flu drugs target immune response, not virus 2
... is probably the largest contaminant of our body. That ... humans has not been proven convincingly. The current Editorial ... Technology reflects on this and concludes that this ... to take measures to reduce our exposure from ...
... that can cause serious heart disease in humans are being ... become a bigger problem in humans. Research published in the ... suggests that brown rats, the biggest and most common rats ... the early 1990s, more than 20 species of Bartonella ...
... by activating a set of proteins known as ... and memory. The body also has chemicals known ... namely N-arachidonoyl ethanolamine (AEA) and 2-arachidonoylglycerol (2-AG). These ... focus of intense efforts to develop new treatments ...
Cached Biology News:Mineral oil contamination in humans: A health problem? 2Scientists discover 21st century plague 2Scripps research team defines new painkilling chemical pathway 2
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product contains a combination of 0.02% methylisothiazolone ... StabilCoat Plus Stabilizer provides optimum performance for ...
... ABgene's Protein Purification Plates are designed ... SDS-PAGE gels. The 96-well plates feature two ... ends of each well. The wells remain ... with buffer, during which time the protein ...
... pLivSelect is a ... for recombinant identification. Recombinant ... colony survival, eliminating the ... screening. This quick and ...
... Western Blot Signal Enhancer does for enzyme-/substrate-based blotting ... it increases the signal up to 10-fold (or ... ,The Western Blot Signal Enhancer membrane treatment ... added to your current Western blotting protocol. ...
Biology Products: